In addition, these treatments resulted in considerable decreases in tumor volume and bone destruction, as demonstrated by Goldner’s trichrome staining (Fig. 4c,d), and the reduced production of TRAP-positive activated osteoclasts on bone surfaces close to cancer cells (Fig. 4c,e). The gene discussed is ACP5; the disease is neoplasm.